Your browser doesn't support javascript.
loading
Epithelial-to-Mesenchymal Transition Drives Invasiveness of Breast Cancer Brain Metastases.
Margarido, Andreia S; Uceda-Castro, Rebeca; Hahn, Kerstin; de Bruijn, Roebi; Kester, Lennart; Hofland, Ingrid; Lohuis, Jeroen; Seinstra, Danielle; Broeks, Annegien; Jonkers, Jos; Broekman, Marike L D; Wesseling, Pieter; Vennin, Claire; Vizoso, Miguel; van Rheenen, Jacco.
Affiliation
  • Margarido AS; Division of Molecular Pathology, Oncode Institute, The Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands.
  • Uceda-Castro R; Division of Molecular Pathology, Oncode Institute, The Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands.
  • Hahn K; Division of Molecular Pathology, Oncode Institute, The Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands.
  • de Bruijn R; Division of Molecular Pathology, Oncode Institute, The Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands.
  • Kester L; Division of Molecular Carcinogenesis, Oncode Institute, The Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands.
  • Hofland I; Division of Molecular Pathology, Oncode Institute, The Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands.
  • Lohuis J; Core Facility Molecular Pathology & Biobanking, The Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands.
  • Seinstra D; Division of Molecular Pathology, Oncode Institute, The Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands.
  • Broeks A; Department of Pathology, Amsterdam University Medical Centers/VUmc and Brain Tumor Center Amsterdam, 1081 HV Amsterdam, The Netherlands.
  • Jonkers J; Core Facility Molecular Pathology & Biobanking, The Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands.
  • Broekman MLD; Division of Molecular Pathology, Oncode Institute, The Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands.
  • Wesseling P; Department of Neurosurgery, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands.
  • Vennin C; Department of Neurosurgery, Haaglanden Medical Center, Lijnbaan, 2512 VA The Hague, The Netherlands.
  • Vizoso M; Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02115, USA.
  • van Rheenen J; Department of Pathology, Amsterdam University Medical Centers/VUmc and Brain Tumor Center Amsterdam, 1081 HV Amsterdam, The Netherlands.
Cancers (Basel) ; 14(13)2022 Jun 25.
Article in En | MEDLINE | ID: mdl-35804890
ABSTRACT
(1)

Background:

an increasing number of breast cancer patients develop lethal brain metastases (BM). The complete removal of these tumors by surgery becomes complicated when cells infiltrate into the brain parenchyma. However, little is known about the nature of these invading cells in breast cancer brain metastasis (BCBM). (2)

Methods:

we use intravital microscopy through a cranial window to study the behavior of invading cells in a mouse model of BCBM. (3)

Results:

we demonstrate that BCBM cells that escape from the metastatic mass and infiltrate into brain parenchyma undergo epithelial-to-mesenchymal transition (EMT). Moreover, cells undergoing EMT revert to an epithelial state when growing tumor masses in the brain. Lastly, through multiplex immunohistochemistry, we confirm the presence of these infiltrative cells in EMT in patient samples. (4)

Conclusions:

together, our data identify the critical role of EMT in the invasive behavior of BCBM, which warrants further consideration to target those cells when treating BCBM.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Cancers (Basel) Year: 2022 Document type: Article Affiliation country: Netherlands

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Cancers (Basel) Year: 2022 Document type: Article Affiliation country: Netherlands
...